Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,337 | -15,003 | -10,098 | -6,590 | -2,973 |
| Depreciation Amortization | 974 | 3,335 | 2,474 | 1,649 | 825 |
| Income taxes - deferred | -902 | -7,252 | -4,386 | -2,825 | -1,584 |
| Accounts payable and accrued liabilities | 938 | -24 | -313 | 23 | 354 |
| Other Working Capital | 1,075 | 2,416 | 1,511 | 1,530 | 2,338 |
| Other Operating Activity | 4,120 | 4,135 | 2,431 | 1,479 | 339 |
| Operating Cash Flow | $-4,132 | $-12,393 | $-8,381 | $-4,734 | $-701 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -69 | -4,592 | -4,024 | -2,677 | -312 |
| Purchase Of Investment | N/A | N/A | -1 | N/A | N/A |
| Other Investing Activity | 32 | -1 | 0 | 0 | 0 |
| Investing Cash Flow | $-37 | $-4,593 | $-4,025 | $-2,677 | $-312 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -100 | -1 | N/A | N/A | N/A |
| Common Stock Issued | 178 | 22,068 | 20,009 | 20,009 | 5,075 |
| Other Financing Activity | 476 | 3,026 | 1,966 | -38 | 283 |
| Financing Cash Flow | $554 | $25,093 | $21,975 | $19,971 | $5,358 |
| Beginning Cash Position | 11,183 | 3,076 | 3,076 | 3,076 | 3,076 |
| End Cash Position | 7,568 | 11,183 | 12,645 | 15,636 | 7,421 |
| Net Cash Flow | $-3,615 | $8,107 | $9,569 | $12,560 | $4,345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,132 | -12,393 | -8,381 | -4,734 | -701 |
| Capital Expenditure | -69 | -4,592 | -4,024 | -2,677 | -312 |
| Free Cash Flow | -4,201 | -16,985 | -12,405 | -7,411 | -1,013 |